Dynavax Technologies (NASDAQ:DVAX) Climbs 3.7% This Week, Taking Five-year Gains to 107%
Dynavax Technologies (NASDAQ:DVAX) Climbs 3.7% This Week, Taking Five-year Gains to 107%
When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really flourishing, you can make more than 100%. For instance, the price of Dynavax Technologies Corporation (NASDAQ:DVAX) stock is up an impressive 107% over the last five years. Better yet, the share price has risen 3.7% in the last week.
當您購買一支股票時,總是存在可能下跌100%的可能性。但是當您選擇一家真正蓬勃發展的公司時,您可以獲得超過100%的回報。例如,德納維製藥公司(納斯達克:DVAX)的股價在過去五年中大幅上漲了107%。更好的是,股價在上週上漲了3.7%。
After a strong gain in the past week, it's worth seeing if longer term returns have been driven by improving fundamentals.
在過去的一週之內,獲得的強勁收益是否表明了長期回報受到基本面的推動值得關注。
While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.
儘管一些人繼續教授有效市場假說,但已經證明市場是過度反應的動態系統,並且投資者並不總是理性的。通過比較每股收益(EPS)和股價的變化情況,我們可以了解投資者對公司的態度如何隨着時間變化而變化。
During the last half decade, Dynavax Technologies became profitable. That kind of transition can be an inflection point that justifies a strong share price gain, just as we have seen here.
在過去的半個十年中,德納維製藥已經盈利。這種轉變可能是一個可以證明股價大幅上升的轉折點,就像我們在這裏看到的一樣。
The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).
該公司的每股收益(隨時間的推移)如下圖所示(單擊可查看確切數字)。
This free interactive report on Dynavax Technologies' earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.
如果您想進一步調查這支股票,德納維製藥的收益、營業收入和現金流的這份免費互動報告是一個很好的起點。
A Different Perspective
不同的觀點
Investors in Dynavax Technologies had a tough year, with a total loss of 21%, against a market gain of about 42%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. On the bright side, long term shareholders have made money, with a gain of 16% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For example, we've discovered 1 warning sign for Dynavax Technologies that you should be aware of before investing here.
德納維製藥的投資者經歷了艱難的一年,總虧損21%,而市場的漲幅約爲42%。即使優質股票的股價有時會下跌,但我們希望在過於感興趣之前看到業務基本指標有所改善。然而,從積極方面看,長期股東已經賺到錢,過去半個世紀年均增長16%。最近的拋售可能是一個機會,因此值得檢查基本數據,看看是否有長期增長趨勢的跡象。我發現長期觀察股價作爲業務績效的一種替代物很有趣。但要真正獲得洞察力,我們還需要考慮其他信息。例如,我們發現了1個關於德納維製藥的警告信號,您在投資之前應該注意。
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.
如果您願意查看另一家公司(具有潛在的更好財務狀況),請不要錯過這個免費的公司列表,證明它們可以增長收益。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
請注意,本文所引述的市場回報反映了目前在美國交易所上市的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
譯文內容由第三人軟體翻譯。